Abnormal aggregation of myeloid-derived suppressor cells in a mouse model of cyclophosphamide-induced premature ovarian failure

References

• Shelling AN. Premature ovarian failure. Reproduction. 2010;140:633–641.
   PubMed Web of Science ®Google Scholar
• Goswami D, Conway GS. POF. Horm Res. 2007;68(4):196–202.
   PubMedGoogle Scholar
• Ceramide-1-phosphate has protective properties against cyclophosphamide-induced ovarian damage in a mice model of premature ovarian failure. Hum Reprod. 2018;33(5):844–859.
   Google Scholar
• Analysis on the level of IL-6, IL-21, AMH in patients with auto-immunity premature ovarian failure and study of correlation. Exp Ther Med. 2018;16:3395–3398.
   Google Scholar
• Ostrand-Rosenberg S, Sinha P. Myeloid-derived suppressor cells: linking inflammation and cancer. J Immunol. 2009;182:4499–4506.
   PubMed Web of Science ®Google Scholar
• Ray P, Arora M, Poe SL, et al. Lung myeloid-derived suppressor cells and regulation of inflammation. Immunol Res. 2011;50:153–158.
   PubMed Web of Science ®Google Scholar
• Youn JI, Nagaraj S, Collazo M, et al. Subsets of myeloid-derived suppressor cells in tumor-bearing mice. J Immunol. 2008;181:5791–5802.
   PubMed Web of Science ®Google Scholar
• Rodriguez PC, Ernstoff MS, Hernandez C, et al. Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes. Cancer Res. 2009;69:1553–1560.
   PubMed Web of Science ®Google Scholar
• Lin Y, Wang B, Shan W, et al. mTOR inhibitor rapamycin induce polymorphonuclear myeloid-derived suppressor cells mobilization and function in protecting against acute graft-versus-host disease after bone marrow transplantation. Clin Immunol. 2018;187:122–131.
   PubMed Web of Science ®Google Scholar
• Fu C, Jiang L, Xu X, et al. STAT4 knockout protects LPS-induced lung injury by increasing of MDSC and promoting of macrophage differentiation. Respir Physiol Neurobiol. 2016;223:16–22.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Bi Y, Yang H, et al. mTOR limits the recruitment of CD11b + Gr1 + Ly6Chigh myeloid-derived suppressor cells in protecting against murine immunological hepatic injury. J Leukoc Biol. 2014;95:961–970.
   PubMed Web of Science ®Google Scholar
• Chen X, Zhang Z, Bi Y, et al. mTOR signaling disruption from myeloid-derived suppressive cells protects against immune-mediated hepatic injury through the HIF1α-dependent glycolytic pathway. J Leukoc Biol. 2016;100:1349–1362.
   PubMed Web of Science ®Google Scholar
• Zhang C, Wang S, Li J, et al. The mTOR signal regulates myeloid-derived suppressor cells differentiation and immunosuppressive function in acute kidney injury. Cell Death Dis. 2017;8:e2695.
   PubMed Web of Science ®Google Scholar
• Zhang BF, Hu Y, Liu X, et al. The role of AKT and FOXO3 in preventing ovarian toxicity induced by cyclophosphamide. PLoS One. 2018;13:e0201136.
   PubMed Web of Science ®Google Scholar
• Pascuali N, Scotti L, Di PM, et al. Ceramide-1-phosphate has protective properties against cyclophosphamide-induced ovarian damage in a mice model of premature ovarian failure. Hum Reprod. 2018;33:844–859.
   PubMed Web of Science ®Google Scholar
• Falcone T, Bedaiwy MA. Fertility preservation and pregnancy outcome after malignancy. Curr Opin Obstet Gynecol. 2005;17:21–26.
   PubMed Web of Science ®Google Scholar
• Blumenfeld Z, Patel B, Leiba R, et al. Gonadotropin-releasing hormone agonist may minimize POF in young women undergoing autologous stem cell transplantation. Fertil Steril. 2012;98:1266–1270.e1.
   PubMed Web of Science ®Google Scholar
• Balachandar S, Dunkel IJ, Khakoo Y, et al. Ovarian function in survivors of childhood medulloblastoma: impact of reduced dose craniospinal irradiation and high-dose chemotherapy with autologous stem cell rescue. Pediatr Blood Cancer. 2015;62:317–321.
   PubMed Web of Science ®Google Scholar
• Stefansdottir A, Fowler PA, Powles-Glover N, et al. Use of ovary culture techniques in reproductive toxicology. Reprod Toxicol. 2014;49:117–135.
   PubMed Web of Science ®Google Scholar
• Liu H, Mai J, Shen J, et al. A novel DNA aptamer for dual targeting of polymorphonuclear myeloid-derived suppressor cells and tumor cells. Theranostics. 2018;8:31–44.
   PubMed Web of Science ®Google Scholar
• Shen M, Wang J, Yu W, et al. A novel MDSC-induced PD-1-PD-L1+ B-cell subset in breast tumor microenvironment possesses immuno-suppressive properties. Oncoimmunology. 2018;7:e1413520.
   PubMed Web of Science ®Google Scholar
• Ma M, Huang W, Kong D. IL-17 inhibits the accumulation of myeloid-derived suppressor cells in breast cancer via activating STAT3. Int Immunopharmacol. 2018;59:148–156.
   PubMed Web of Science ®Google Scholar
• Zöller M, Zhao K, Kutlu N, et al. Immunoregulatory effects of myeloid-derived suppressor cell exosomes in mouse model of autoimmune alopecia areata. Front Immunol. 2018;9:1279.
   PubMed Web of Science ®Google Scholar
• Leiber A, Schwarz J, Kostlin N, et al. Neonatal myeloid derived suppressor cells show reduced apoptosis and immunosuppressive activity upon infection with Escherichia coli. Eur J Immunol. 2017;47:1009–1021.
   PubMed Web of Science ®Google Scholar
• Laplante M, Sabatini DM. mTOR signaling in growth control and disease. Cell. 2012;149:274–293.
   PubMed Web of Science ®Google Scholar
• Welte T, Kim IS, Tian L, et al. Erratum: oncogenic mTOR signalling recruits myeloid-derived suppressor cells to promote tumour initiation. Nat Cell Biol. 2016;18:822.
   PubMed Web of Science ®Google Scholar
• Miller RA, Harrison DE, Astle CM, et al. Rapamycin, but not resveratrol or simvastatin, extends life span of genetically heterogeneous mice. J Gerontol A Biol Sci Med Sci. 2011;66:191–201.
   PubMed Web of Science ®Google Scholar
• Dou X, Sun Y, Li J, et al. Short-term rapamycin treatment increases ovarian lifespan in young and middle-aged female mice. Aging Cell. 2017;16:825–836.
   PubMed Web of Science ®Google Scholar
• Cheng Y, Kim J, Li XX, et al. Promotion of ovarian follicle growth following mTOR activation: synergistic effects of AKT stimulators. PLoS One. 2015;10:e0117769.
   PubMed Web of Science ®Google Scholar
• Adhikari D, Liu K. mTOR signaling in the control of activation of primordial follicles. Cell Cycle. 2010;9:1673–1684.
   PubMed Web of Science ®Google Scholar
• Tong Y, Li F, Lu Y, et al. Rapamycin-sensitive mTORC1 signaling is involved in physiological primordial follicle activation in mouse ovary. Mol Reprod Dev. 2013;80:1018–1034.
   PubMed Web of Science ®Google Scholar